Structure

(-)-1,2-Bis((2R,5R)-2,5-diethylphospholano)benzene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate, 98+% (R,R)-Et-DUPHOS-Rh

CAS
228121-39-9
Catalog Number
ACM228121399
Category
Other Products
Molecular Weight
660.371g/mol
Molecular Formula
C30H48BF4P2Rh-;

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
228121-39-9;[(R,R)Ethyl-DuPhosRh(COD)]BF4;MFCD01862464;DTXSID50459685;(-)-1,2-Bis((2R,5R)-2,5-diethylphospholano)benzene(cyclooctadiene)rhodium(l) tetrafluoroborate;J-014866;1,2-Bis[(2R,5R)-2,5-diethylphospholano]benzene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate;
IUPAC Name
(1Z,5Z)-cycloocta-1,5-diene;(2R,5R)-1-[2-[(2R,5R)-2,5-diethylphospholan-1-yl]phenyl]-2,5-diethylphospholane;rhodium;tetrafluoroborate;
SMILES
[B-](F)(F)(F)F.CCC1CCC(P1C2=CC=CC=C2P3C(CCC3CC)CC)CC.C1CC=CCCC=C1.[Rh];
InChI
InChI=1S/C22H36P2.C8H12.BF4.Rh/c1-5-17-13-14-18(6-2)23(17)21-11-9-10-12-22(21)24-19(7-3)15-16-20(24)8-4;1-2-4-6-8-7-5-3-1;2-1(3,4)5;/h9-12,17-20H,5-8,13-16H2,1-4H3;1-2,7-8H,3-6H2;;/q;;-1;/b;2-1-,8-7-;;/t17-,18-,19-,20-;;;/m1.../s1;
InChI Key
XIOPHSBHVOCZMM-KYOOHHHUSA-N;
Application
Ligand used in asymmetric hydrogenation of 2-methylenesuccinamic acid.

Ligand used for the Rh-catalyzed asymmetric hydrogenation of α-aminomethylacrylates.
Complexity
414
Covalently-Bonded Unit Count
4
Defined Atom Stereocenter Count
4
Defined Bond Stereocenter Count
2
Exact Mass
660.232g/mol
Formal Charge
-1
H-Bond Acceptor
5
Heavy Atom Count
38
Monoisotopic Mass
660.232g/mol
Rotatable Bond Count
6
Topological Polar Surface Area
0A^2
December 15, 2022


Works very well
This product works very well

Please kindly note that our products are for research use only.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Shopping basket
Loading...
Loading...
Download PDF documentDownload
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.